Endra Life Sciences
(NASDAQ) NDRA
Endra Life Sciences Financials at a Glance
Market Cap
$5.79M
Revenue (TTM)
$0.00
Net Income (TTM)
-$7.30M
EPS (TTM)
-$8.15
P/E Ratio
-0.56
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$4.53
Volume
24
Open
$4.44
Price
$4.53
Volume
24
Open
$4.44
Previous Close
$4.56
Daily Range
$4.44 - $4.73
52-Week Range
$2.96 - $11.96
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.15 (Average)
Price
$4.53
Volume
24
Open
$4.44
Previous Close
$4.56
Daily Range
$4.44 - $4.73
52-Week Range
$2.96 - $11.96
Estimated Earnings Date
Aug 13, 2026
NDRA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Endra Life Sciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
11
CEO
Alexander Y. Tokman
Website
www.endrainc.comHeadquarters
Ann Arbor, MI 48105-1570, US
NDRA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-413%
Return on Capital
-2%
Return on Assets
-2%
Earnings Yield
-1.79%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.79M
Shares Outstanding
1.27M
Volume
24
Avg. Volume
22.97K
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$5.76M
EBITDA
-$6.87M
Operating Cash Flow
-$5.18M
Capital Expenditure
-$17.28K
Free Cash Flow
-$5.20M
Cash & ST Invst.
$762.37K
Total Debt
$492.35K
Endra Life Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$39.72K
N/A
Gross Margin
0.00%
N/A
Market Cap
$5.79M
N/A
Market Cap/Employee
$275.79K
N/A
Employees
21
N/A
Net Income
-$1.31M
-26.5%
EBITDA
-$1.27M
-28.4%
Quarterly Fundamentals
Total Cash
$356.46K
-82.7%
Total Debt
$461.21K
-21.5%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$327.25K
-29.0%
Short Term Debt
$133.95K
+6.2%
Return on Assets
-2.12%
N/A
Return on Invested Capital
-2.48%
N/A
Free Cash Flow
-$1.12M
+14.6%
Operating Cash Flow
-$1.12M
+13.4%